SciClone Pharmaceuticals (02291.HK) repurchased 35,000 shares for approximately HK$429,700 on September 29.

Zhitong Finance APP News, Xintai Medical (02291.HK) announced that on September 29, 2026, the company spent approximately HK$429,700 to repurchase 35,000 H shares at a repurchase price of HK$12.18 to HK$12.31 per share.